Backed By a Genentech (RHHBY) Alum, NGM Looks Like it Could be the Next Biotech IPO
SoCal Biotech AtheroNova (AHRO) and its Subsidiary File for Chapter 11
With Two Ex-Elan (ELN) Execs at the Helm, Bay Area's Serenus Nabs $43 Million
CALBIO15: Johnson & Johnson (JNJ) Unveils New Innovation Center, Looks to Spark Creative Revolution in the Bay: Exec
A Peek Inside Ex-Dendreon (DNDN) CEO, Amgen (AMGN) Scientists' New Startup Alpine Immune Sciences
Genentech (RHHBY)'s Controversial Distribution Move Deemed a Failure: Survey
Teva (TEVA) Sells Plant, 25 Drugs to G&W Laboratories; 280 Jobs Salvaged
Sun Pharma (SUNPHARMA.NS) Snaps Up GlaxoSmithKline (GSK)'s Opiates Business
Vertex (VRTX) Terminates Leases on Three Properties in Cambridge, Massachusetts
Mersana Therapeutics Nabs $35 Million And A New CEO
CALBIO15: Investors Will "Set Higher Bar" for Biotech IPOs in 2015 As Market Corrects, Says Panel
CALBIO15: Gene Therapy in "Second Honeymoon" Phase as Companies, Investors Swarm
CALBIO15: Bill & Melinda Gates Foundation Exec Says Ebola Vaccine Will Arrive in 2016, Takes Aim at Vaccination Critics
AstraZeneca PLC (AZN) Chairman Urges Executive Bonuses Be Linked to Sales Goal Pledge
Baxter International (BAX) Starts Hiring in Anticipation of Planned Drug Spinout Baxalta
Boston Scientific (BSX) Snags Endo International (ENDP)'s Urology Portfolio in Deal Worth $1.65 Billion
Cardinal Health (CAH) Ponies Up $1.944 Billion Cash for Johnson & Johnson (JNJ)'s Cordis (JNJ)
Shares Fall as the FDA Rejects Pacira (PCRX)'s Application for Expanded Use of Pain Drug
See All News >
//-->